These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36357828)

  • 1. Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin.
    Ekpo UF; Eneanya OA; Nwankwo EN; Soneye IY; Weil GJ; Fischer PU; Nwaorgu OC
    BMC Infect Dis; 2022 Nov; 22(1):832. PubMed ID: 36357828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
    Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
    Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Hypoendemic Onchocerciasis in
    Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
    Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
    Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
    Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
    Anagbogu IN; Saka YA; Surakat OA; Okoronkwo C; Davies E; Oyale P; Ekpo UF; Amazigo UV; Barbre K; Igbe M; Nyior A; Jacob SM; Gideon Nteun U; Abubakar Umar Z
    Parasit Vectors; 2022 Jun; 15(1):201. PubMed ID: 35698164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
    Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
    Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.
    Griswold E; Eigege A; Ityonzughul C; Emukah E; Miri ES; Anagbogu I; Saka YA; Kadiri S; Adelamo S; Ugbadamu P; Ikogho C; Richards FO
    Am J Trop Med Hyg; 2018 Aug; 99(2):396-403. PubMed ID: 29943709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
    Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
    Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
    Richards FO; Eigege A; Umaru J; Kahansim B; Adelamo S; Kadimbo J; Danboyi J; Mafuyai H; Saka Y; Noland GS; Anyaike C; Igbe M; Rakers L; Griswold E; Unnasch TR; Nwoke BEB; Miri E
    Am J Trop Med Hyg; 2020 Mar; 102(3):582-592. PubMed ID: 32043442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
    Dolo H; Coulibaly ME; Sow M; Coulibaly YI; Doumbia M; Sangare M; Sanogo A; Dembele B; Guindo B; Coulibaly M; Keita M; Soumaoro L; Diarra D; Dicko B; Hamill L; Doumbia S; Sangho H; Sangare Y; Zhang Y; Tallant J; Yaro AS; Mackenzie C; Nutman TB; Boakye D
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011632. PubMed ID: 37967137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
    Sam-Wobo SO; Adeleke MA; Jayeola OA; Adeyi AO; Oluwole AS; Ikenga M; Lawniye F; Gazama J; Kagni A; Kosoko TO; Agbeyangi O; Bankole S; Toé L; Mafiana CF; Yameogo L
    J Vector Borne Dis; 2012 Jun; 49(2):101-4. PubMed ID: 22898482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
    Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
    BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
    Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
    Osue HO
    Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin.
    Chikezie FM; Opara KN; Ubulom PME; Yaro CA; Al-Akeel RK; Osei-Atweneboana MY; Alexiou A; Papadakis M; Batiha GE
    Sci Rep; 2023 Apr; 13(1):5413. PubMed ID: 37012274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.